Bio-Rad Laboratories, Inc.
Hedge Funds Holdings
Last updated:
Bio-Rad Laboratories, Inc.‘s stocks are currently a part of 438 hedge funds’ portfolios, which represents 58.62% of the total amount of its stocks outstanding. This makes up a total of 17.46M shares of Bio-Rad Laboratories, Inc.. Compared to the previous quarter, the number fell by -7.43% or -1.40M shares fewer. As for the holding position changes, 40.64% (178) of current hedge fund investors increased the number of shares held, 31.74% (139) of current holders sold a part of the shares held, and 12.33% (54) closed the holdings completely. 47 hedge funds are new holders of Bio-Rad Laboratories, Inc. stock in Q3 2022, it is 10.73% of total holders.
Hedge funds holding Bio-Rad Laboratories (Q4 2017 – Q3 2022)
| Q4 2017 | 299 |
|---|---|
| Q1 2018 | 311 |
| Q2 2018 | 321 |
| Q3 2018 | 339 |
| Q4 2018 | 324 |
| Q1 2019 | 344 |
| Q2 2019 | 328 |
| Q3 2019 | 351 |
| Q4 2019 | 379 |
| Q1 2020 | 399 |
| Q2 2020 | 460 |
| Q3 2020 | 470 |
| Q4 2020 | 481 |
| Q1 2021 | 480 |
| Q2 2021 | 495 |
| Q3 2021 | 494 |
| Q4 2021 | 521 |
| Q1 2022 | 497 |
| Q2 2022 | 482 |
| Q3 2022 | 438 |
Hedge funds changes in Bio-Rad Laboratories positions (Q4 2017 – Q3 2022)
| Q4 2017 | 55 | 100 | 101 | 24 | 19 |
|---|---|---|---|---|---|
| Q1 2018 | 44 | 97 | 120 | 27 | 23 |
| Q2 2018 | 39 | 108 | 125 | 29 | 20 |
| Q3 2018 | 45 | 113 | 132 | 26 | 23 |
| Q4 2018 | 44 | 117 | 117 | 60 | -14 |
| Q1 2019 | 62 | 131 | 109 | 42 | 0 |
| Q2 2019 | 40 | 103 | 130 | 52 | 3 |
| Q3 2019 | 53 | 147 | 96 | 29 | 26 |
| Q4 2019 | 78 | 136 | 111 | 44 | 10 |
| Q1 2020 | 64 | 141 | 138 | 39 | 17 |
| Q2 2020 | 99 | 159 | 152 | 37 | 13 |
| Q3 2020 | 64 | 175 | 172 | 50 | 9 |
| Q4 2020 | 75 | 177 | 170 | 57 | 2 |
| Q1 2021 | 62 | 201 | 144 | 60 | 13 |
| Q2 2021 | 58 | 191 | 166 | 41 | 39 |
| Q3 2021 | 48 | 170 | 191 | 43 | 42 |
| Q4 2021 | 82 | 184 | 191 | 42 | 22 |
| Q1 2022 | 63 | 187 | 185 | 78 | -16 |
| Q2 2022 | 60 | 160 | 196 | 70 | -4 |
| Q3 2022 | 47 | 178 | 139 | 54 | 20 |
Hedge funds changes in Bio-Rad Laboratories stock options (Q4 2017 – Q3 2022)
| Q4 2017 | 2,100,000 | 8,138,000 |
|---|---|---|
| Q1 2018 | 3,076,000 | 4,976,000 |
| Q2 2018 | 2,423,000 | 2,279,000 |
| Q3 2018 | 407,000 | 3,256,000 |
| Q4 2018 | 4,895,000 | 7,918,000 |
| Q1 2019 | 60,892,000 | 64,224,000 |
| Q2 2019 | 17,005,000 | 4,845,000 |
| Q3 2019 | 8,221,000 | 27,587,000 |
| Q4 2019 | 26,198,000 | 8,806,000 |
| Q1 2020 | 6,443,000 | 12,650,000 |
| Q2 2020 | 11,242,000 | 10,505,000 |
| Q3 2020 | 8,916,000 | 14,690,000 |
| Q4 2020 | 13,493,000 | 15,383,000 |
| Q1 2021 | 22,490,000 | 14,161,000 |
| Q2 2021 | 39,366,000 | 77,186,000 |
| Q3 2021 | 76,167,000 | 53,562,000 |
| Q4 2021 | 40,952,000 | 97,092,000 |
| Q1 2022 | 56,999,000 | 83,301,000 |
| Q2 2022 | 32,063,000 | 92,962,000 |
| Q3 2022 | 75,627,000 | 87,641,000 |